Several new apps are making it easier for doctors and patients to conduct clinical trials.
Neal Ungerleider (@nealunger) is a Los Angeles-based writer and journalist. His work appears in Fast Company, the Los Angeles Times op-ed section, Wired, Slate, and many other venues. Neal’s honest, dorky hope is that mobile apps and better patient-facing technology will decrease the time for lifesaving innovations to make it to the general public.
GV, Google's venture capital arm, is investing in several promising biotechnology startups.